Oscar Health, Inc. (OSCR) Guidance & Earnings Results
On 2026-08-06 Oscar Health, Inc. raised guidance: "Earnings from operations guidance raised to $500M-$700M from $250M-$450M; MLR guidance improved to 81.5%-82.5% from 82.4%-83.4%; SG&A ratio guidance improved to 15.6%-16.1% from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OSCROscar Health, Inc.Follow OSCR — free
—
Price chart with a free account
- Market cap
- 9.6B
- P/E TTM
- 18.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 Aug 26 | Raised | Earnings from operations guidance raised to $500M-$700M from $250M-$450M; MLR guidance improved to 81.5%-82.5% from 82.4%-83.4%; SG&A ratio guidance improved to 15.6%-16.1% from 15.8%-16.3%. · full year |
| 6 May 26 | Reaffirmed | Reaffirmed full year 2026 outlook across all metrics · full year |
| 6 Nov 25 | Reaffirmed | FY2025 revenue $12.0-12.2B, MLR 86-87%, SG&A 17.1-17.6%, operating loss $(300)-(200)M · full year |
| 6 Aug 25 | Reaffirmed | Reaffirmed updated full year 2025 outlook across all metrics as provided in preliminary financial results press release dated July 22, 2025. · full year |
Oscar Health, Inc. — questions
- What guidance did Oscar Health, Inc. give?
- On 2026-08-06: "Earnings from operations guidance raised to $500M-$700M from $250M-$450M; MLR guidance improved to 81.5%-82.5% from 82.4%-83.4%; SG&A ratio guidance improved to 15.6%-16.1% from 15.8%-16.3%."
- When does Oscar Health, Inc. report earnings?
- Oscar Health, Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from Oscar Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.